CSIMarket
 


Volitionrx Limited  (VNRX)
Other Ticker:  
 


Volitionrx Limited's Free Cash Flow Margin by quarter

Trends, Rankings, Statistics



VNRX Free Cash Flow Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 103.79 % 405.02 % 444.15 % 31.17 % 740.7 %
Seq. Revenue Change 47.67 % -23.62 % 44.39 % 25.14 % 265.94 %
Revenue In Millions $0.24 $0.17 $0.22 $0.15 $0.12
Free Cash Flow Margin - -5095.55 % -3396.78 % -5837.3 % -4329.56 %
Free Cash Flow Margin Total Ranking # 6 # # # #
Free Cash Flow In Millions $6.45 $-8.42 $-7.35 $-8.74 $-5.18
Y / Y Free Cash Flow Change - - - - -
Seq. Free Cash Flow Change - - - - -


Commenting fourth Quarter 2023 Free Cash Flow Margin
Company's Free Cash Flow Margin improved in IV. Quarter to 2642.81 %, a new company high.

Observing fourth quarter 2023 results within In Vitro & In Vivo Diagnostic Substances industry Volitionrx Limited has achieved highest Free Cash Flow Margin. While Free Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 6.

VNRX's Free Cash Flow Margin fourth quarter 2023 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 1
Healthcare Sector # 1
Overall # 6

Free Cash Flow Margin Statistics
High Average Low
2642.81 % 2630.32 % 2617.83 %
(Dec 31 2023)   (Mar 31 2022)




Other Free Cash Flow Margin Profitability Ratios
VNRX's Cumulative Free Cash Flow Margin
In Vitro & In Vivo Diagnostic Substances Industry Free Cash Flow Margin Trends and Statistics
Healthcare Sector Free Cash Flow Margin Statistics
Free Cash Flow Margin Profitability Trends for overall market
VNRX's Free Cash Flow Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Margin
Lowest Ranking Free Cash Flow Margin
Free Cash Flow Margin Profit Margin for VNRX's Competitors
Free Cash Flow Margin Profit Margin for Volitionrx Limited's Suppliers
Free Cash Flow Margin Profit Margin for VNRX's Customers

You may also want to know
VNRX's Annual Growth Rates VNRX's Profitability Ratios VNRX's Asset Turnover Ratio VNRX's Dividend Growth
VNRX's Roe VNRX's Valuation Ratios VNRX's Financial Strength Ratios VNRX's Free Cash Flow Growth
VNRX's Roa VNRX's Inventory Turnover Ratio VNRX's Growth Rates VNRX's Dividend Comparisons


Companies with similar Free Cash Flow Margin in the quarter ending Dec 31 2023, within In Vitro & In Vivo Diagnostic Substances Industry Free Cash Flow MarginDec 31 2023 MRQ Free Cash FlowDec 31 2023 MRQ Revenue
Volitionrx Limited  2,642.81 %$ 6.448 $ 0.244 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com